Advanced adhesion and targeting strategies to prolong gut residence time and improve eLBP efficacy in colonic diseases
{{output}}
Engineered live biotherapeutic products (eLBPs) are genetically modified microorganisms being explored as a novel treatment modality for gastrointestinal (GI) diseases. The therapeutic potential is driven by their ability to selectively interact with host tiss... ...